Clinical Trial Update: A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial investigating atezolizumab with chemotherapy vs placebo with chemotherapy in neoadjuvant treatment for early-stage triple-negative breast cancer; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Chemotherapy (chemotherapy)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Triple-negative Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2021-06-02